Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.
暂无分享,去创建一个
Helmut Neumann | Michael Vieth | Markus F Neurath | Cord Langner | Jonas Mudter | C. Langner | M. Neurath | M. Vieth | H. Neumann | J. Mudter
[1] I. Brock,et al. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms. , 2003, Human pathology.
[2] C. Bernstein,et al. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.
[3] Bernhard Nafe,et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. , 2003, Gastroenterology.
[4] Helmut Neumann,et al. New endoscopic approaches in IBD. , 2011, World journal of gastroenterology.
[5] M. Vieth,et al. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment , 2005, Gut.
[6] H. Mitomi,et al. Decreased expression of CD44, alpha‐catenin, and deleted colon carcinoma and altered expression of beta‐catenin in ulcerative colitis‐associated dysplasia and carcinoma, as compared with sporadic colon neoplasms , 2000 .
[7] C. Loddenkemper. Diagnostic Standards in the Pathology of Inflammatory Bowel Disease , 2009, Digestive Diseases.
[8] S. Cross,et al. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. , 2005, Endoscopy.
[9] Helmut Neumann,et al. Confocal laser endomicroscopy: technical advances and clinical applications. , 2010, Gastroenterology.
[10] C. Florent,et al. Dysplasia and cancer in ulcerative colitis. , 1989, Hepato-gastroenterology.
[11] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[12] N. Harpaz,et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. , 1995, Cancer research.
[13] M. Esaki,et al. Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study. , 2007, Gastrointestinal endoscopy.
[14] R. Odze. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. , 1999 .
[15] E. Dekker,et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions , 2008, Gut.
[16] R. Kiesslich,et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. , 2007, Gastroenterology.
[17] M. Neurath,et al. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications , 2006, Gut.
[18] T. Rognum,et al. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. , 1998, Molecular pathology : MP.
[19] M F Neurath,et al. Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight , 2004, Gut.
[20] M. Vieth,et al. Die schwierige Differenzialdiagnose der sporadischen Adenome und kolitisassoziierten intraepithelialen Neoplasien bei Colitis ulcerosa , 2003, Der Pathologe.
[21] P. Malfertheiner,et al. Double-balloon enteroscopy-assisted virtual chromoendoscopy for small-bowel disorders – a case series , 2009, Endoscopy.
[22] K. Abrams,et al. The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.
[23] Shinji Tanaka,et al. Pragmatic classification of superficial neoplastic colorectal lesions. , 2009, Gastrointestinal endoscopy.
[24] S. Cross,et al. Confocal endomicroscopy in ulcerative colitis: differentiating dysplasia-associated lesional mass and adenoma-like mass. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[25] M. Vieth,et al. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. , 1999, Human pathology.
[26] A. Forbes,et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis , 2004, Gut.
[27] R. Odze,et al. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. , 1999, Gastroenterology.
[28] N. Shepherd,et al. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. , 2009, Gastroenterology.
[29] P. Malfertheiner,et al. Advanced colon polypectomy. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[30] M. Stolte,et al. Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis. , 1993, Zeitschrift fur Gastroenterologie.
[31] D. Forman,et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia , 2003, Gut.
[32] M. Neurath,et al. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. , 2008, Current drug targets.
[33] R. Haggitt,et al. Cancer surveillance in ulcerative colitis. , 1991, Gastroenterology.
[34] A. Forbes,et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. , 2004, Gastrointestinal endoscopy.
[35] R. Odze,et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[36] D. Ransohoff,et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. , 2008, Gastrointestinal endoscopy.
[37] D. Present,et al. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. , 2005, Inflammatory bowel diseases.
[38] T. Fujimori,et al. Colonoscopic diagnosis of dysplasia and early cancer in longstanding colitis. , 1995, Journal of gastroenterology.
[39] M. Neurath,et al. Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. , 2007, Inflammatory bowel diseases.
[40] R. Odze,et al. Genetic Alterations in Chronic Ulcerative Colitis-Associated Adenoma-Like DALMs Are Similar to Non-Colitic Sporadic Adenomas , 2000, The American journal of surgical pathology.
[41] C. Williams,et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.
[42] S. Cross,et al. Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. , 2004, Gastroenterology.
[43] M. Stolte,et al. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas. , 1998, Human pathology.
[44] R. Odze,et al. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. , 2009, Inflammatory bowel diseases.
[45] F. Waldman,et al. The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas , 2002, Cancer.